戴維醫療(300314.SZ):新產品嬰兒培養箱獲得醫療器械註冊證
格隆匯4月7日丨戴維醫療(300314.SZ)公佈,近日,公司的新產品嬰兒培養箱獲得了國家藥品監督管理局頒發的《醫療器械註冊證》。
嬰兒培養箱用於醫療機構中為低體重嬰兒、病危病弱嬰兒、早產兒提供温濕度適宜的培養治療環境,可選功能可用於對患者的心電、無創血壓、血氧飽和度、脈率、呼末二氧化碳生理參數進行監測。
公司表示,以上產品醫療器械註冊證的取得,有利於豐富公司產品線,進一步提高公司的核心競爭力,對公司未來的經營成果將產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.